Global Non-invasive Parenteral Screening Instruments Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

TABLE OF CONTENTS

1 Report Overview

• 1.1 Research Scope
• 1.2 Market Segment by Type
  • 1.2.1 Global Non-invasive Parenteral Screening Instruments Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
  • 1.2.2 Ultrasound Devices
  • 1.2.3 Next-Generation Sequencing Systems
  • 1.2.4 Polymerase Chain Reaction Instruments
  • 1.2.5 Microarrays
  • 1.2.6 Others
• 1.3 Market Segment by Application
  • 1.3.1 Global Non-invasive Parenteral Screening Instruments Market Share by Application (2017 VS 2021 VS 2028)
  • 1.3.2 Diagnostic Laboratories
  • 1.3.3 Hospitals
• 1.4 Study Objectives
• 1.5 Years Considered

2 Market Perspective

• 2.1 Global Non-invasive Parenteral Screening Instruments Market Size (2017-2028)
  • 2.1.1 Global Non-invasive Parenteral Screening Instruments Revenue (2017-2028)
  • 2.1.2 Global Non-invasive Parenteral Screening Instruments Sales (2017-2028)
• 2.2 Global Non-invasive Parenteral Screening Instruments Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
  • 2.2.1 Global Non-invasive Parenteral Screening Instruments Sales by Regions (2017-2022)
  • 2.2.2 Global Non-invasive Parenteral Screening Instruments Revenue by Regions (2017-2022)
• 2.3 Global Non-invasive Parenteral Screening Instruments Market Size Forecast by Region
  • 2.3.1 Global Non-invasive Parenteral Screening Instruments Sales Forecast by Region (2023-2028)
  • 2.3.2 Global Non-invasive Parenteral Screening Instruments Revenue Forecast by Region (2023-2028)
• 2.4 Global Top Non-invasive Parenteral Screening Instruments Regions (Countries) Ranking by Market Size
• 2.5 Non-invasive Parenteral Screening Instruments Market Dynamics
  • 2.5.1 Non-invasive Parenteral Screening Instruments Market Trends
  • 2.5.2 Non-invasive Parenteral Screening Instruments Market Drivers
  • 2.5.3 Non-invasive Parenteral Screening Instruments Market Challenges
  • 2.5.4 Non-invasive Parenteral Screening Instruments Market Restraints

3 Competitive Landscape by Manufacturers

• 3.1 Global Top Non-invasive Parenteral Screening Instruments Manufacturers by Sales (2017-2022)
  • 3.1.1 Global Non-invasive Parenteral Screening Instruments Sales by Manufacturers (2017-2022)
  • 3.1.2 Global Non-invasive Parenteral Screening Instruments Sales Market Share by Manufacturers (2017-2022)
  • 3.1.3 Global 5 and 10 Largest Manufacturers by Non-invasive Parenteral Screening Instruments Sales in 2021
• 3.2 Global Top Manufacturers Non-invasive Parenteral Screening Instruments by Revenue
  • 3.2.1 Global Non-invasive Parenteral Screening Instruments Revenue by Manufacturers (2017-2022)
  • 3.2.2 Top Non-invasive Parenteral Screening Instruments Manufacturers Covered: Ranking by Revenue
  • 3.2.3 Global Non-invasive Parenteral Screening Instruments Revenue Share by Manufacturers (2017-2022)
  • 3.2.4 Global Non-invasive Parenteral Screening Instruments Market Concentration Ratio (CR5 and HHI)
• 3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Non-invasive Parenteral Screening Instruments as of 2021)
• 3.4 Global Non-invasive Parenteral Screening Instruments Average Selling Price (ASP) by Manufacturers
• 3.5 Key Manufacturers Non-invasive Parenteral Screening Instruments Plants/Factories Distribution and Area Served
• 3.6 Date of Key Manufacturers Enter into Non-invasive Parenteral Screening Instruments Market
• 3.7 Key Manufacturers Non-invasive Parenteral Screening Instruments Product Offered
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Global Non-invasive Parenteral Screening Instruments Market Size by Type

• 4.1 Global Non-invasive Parenteral Screening Instruments Historic Market Review by Type (2017-2022)
  • 4.1.1 Global Non-invasive Parenteral Screening Instruments Sales Market Share by Type (2017-2022)
  • 4.1.2 Global Non-invasive Parenteral Screening Instruments Revenue Market Share by Type (2017-2022)
  • 4.1.3 Non-invasive Parenteral Screening Instruments Price by Type (2017-2022)
• 4.2 Global Non-invasive Parenteral Screening Instruments Market Estimates and Forecasts by Type (2023-2028)
  • 4.2.1 Global Non-invasive Parenteral Screening Instruments Sales Forecast by Type (2023-2028)
  • 4.2.2 Global Non-invasive Parenteral Screening Instruments Revenue Forecast by Type (2023-2028)
  • 4.2.3 Non-invasive Parenteral Screening Instruments Price Forecast by Type (2023-2028)

5 Global Non-invasive Parenteral Screening Instruments Market Size by Application

• 5.1 Global Non-invasive Parenteral Screening Instruments Historic Market Review by Application (2017-2022)
  • 5.1.1 Global Non-invasive Parenteral Screening Instruments Sales Market Share by Application (2017-2022)
  • 5.1.2 Global Non-invasive Parenteral Screening Instruments Revenue Market Share by Application (2017-2022)
  • 5.1.3 Non-invasive Parenteral Screening Instruments Price by Application (2017-2022)
• 5.2 Global Non-invasive Parenteral Screening Instruments Market Estimates and Forecasts by Application (2023-2028)
  • 5.2.1 Global Non-invasive Parenteral Screening Instruments Sales Forecast by Application (2023-2028)
  • 5.2.2 Global Non-invasive Parenteral Screening Instruments Revenue Forecast by Application (2023-2028)
  • 5.2.3 Non-invasive Parenteral Screening Instruments Price Forecast by Application (2023-2028)

6 North America

• 6.1 North America Non-invasive Parenteral Screening Instruments Sales Breakdown by Company
  • 6.1.1 North America Non-invasive Parenteral Screening Instruments Sales by Company (2017-2022)
  • 6.1.2 North America Non-invasive Parenteral Screening Instruments Revenue by Company (2017-2022)
• 6.2 North America Non-invasive Parenteral Screening Instruments Market Size by Type
  • 6.2.1 North America Non-invasive Parenteral Screening Instruments Sales by Type (2017-2028)
  • 6.2.2 North America Non-invasive Parenteral Screening Instruments Revenue by Type (2017-2028)
• 6.3 North America Non-invasive Parenteral Screening Instruments Market Size by Application
  • 6.3.1 North America Non-invasive Parenteral Screening Instruments Sales by Application (2017-2028)
  • 6.3.2 North America Non-invasive Parenteral Screening Instruments Revenue by Application (2017-2028)
• 6.4 North America Non-invasive Parenteral Screening Instruments Market Size by Country
  • 6.4.1 North America Non-invasive Parenteral Screening Instruments Sales by Country (2017-2028)
  • 6.4.2 North America Non-invasive Parenteral Screening Instruments Revenue by Country (2017-2028)
  • 6.4.3 U.S.
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Non-invasive Parenteral Screening Instruments Sales Breakdown by Company
  • 7.1.1 Europe Non-invasive Parenteral Screening Instruments Sales by Company (2017-2022)
  • 7.1.2 Europe Non-invasive Parenteral Screening Instruments Revenue by Company (2017-2022)
• 7.2 Europe Non-invasive Parenteral Screening Instruments Market Size by Type
  • 7.2.1 Europe Non-invasive Parenteral Screening Instruments Sales by Type (2017-2028)
  • 7.2.2 Europe Non-invasive Parenteral Screening Instruments Revenue by Type (2017-2028)
• 7.3 Europe Non-invasive Parenteral Screening Instruments Market Size by Application
  • 7.3.1 Europe Non-invasive Parenteral Screening Instruments Sales by Application (2017-2028)
  • 7.3.2 Europe Non-invasive Parenteral Screening Instruments Revenue by Application (2017-2028)
• 7.4 Europe Non-invasive Parenteral Screening Instruments Market Size by Country
  • 7.4.1 Europe Non-invasive Parenteral Screening Instruments Sales by Country (2017-2028)
  • 7.4.2 Europe Non-invasive Parenteral Screening Instruments Revenue by Country (2017-2028)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Non-invasive Parenteral Screening Instruments Sales Breakdown by Company
  • 8.1.1 Asia Pacific Non-invasive Parenteral Screening Instruments Sales by Company (2017-2022)
  • 8.1.2 Asia Pacific Non-invasive Parenteral Screening Instruments Revenue by Company (2017-2022)
• 8.2 Asia Pacific Non-invasive Parenteral Screening Instruments Market Size by Type
  • 8.2.1 Asia Pacific Non-invasive Parenteral Screening Instruments Sales by Type (2017-2028)
  • 8.2.2 Asia Pacific Non-invasive Parenteral Screening Instruments Revenue by Type (2017-2028)
• 8.3 Asia Pacific Non-invasive Parenteral Screening Instruments Market Size by Application
  • 8.3.1 Asia Pacific Non-invasive Parenteral Screening Instruments Sales by Application (2017-2028)
  • 8.3.2 Asia Pacific Non-invasive Parenteral Screening Instruments Revenue by Application (2017-2028)
• 8.4 Asia Pacific Non-invasive Parenteral Screening Instruments Market Size by Region
  • 8.4.1 Asia Pacific Non-invasive Parenteral Screening Instruments Sales by Region
  • 8.4.2 Asia Pacific Non-invasive Parenteral Screening Instruments Revenue by Region
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 India
  • 8.4.7 Australia
  • 8.4.8 Taiwan
  • 8.4.9 Indonesia
  • 8.4.10 Thailand
  • 8.4.11 Malaysia
  • 8.4.12 Philippines
  • 8.4.13 Vietnam

9 Latin America

• 9.1 Latin America Non-invasive Parenteral Screening Instruments Sales Breakdown by Company
  • 9.1.1 Latin America Non-invasive Parenteral Screening Instruments Sales by Company (2017-2022)
  • 9.1.2 Latin America Non-invasive Parenteral Screening Instruments Revenue by Company (2017-2022)
• 9.2 Latin America Non-invasive Parenteral Screening Instruments Market Size by Type
  • 9.2.1 Latin America Non-invasive Parenteral Screening Instruments Sales by Type (2017-2028)
  • 9.2.2 Latin America Non-invasive Parenteral Screening Instruments Revenue by Type (2017-2028)
• 9.3 Latin America Non-invasive Parenteral Screening Instruments Market Size by Application
  • 9.3.1 Latin America Non-invasive Parenteral Screening Instruments Sales by Application (2017-2028)
  • 9.3.2 Latin America Non-invasive Parenteral Screening Instruments Revenue by Application (2017-2028)
• 9.4 Latin America Non-invasive Parenteral Screening Instruments Market Size by Country
  • 9.4.1 Latin America Non-invasive Parenteral Screening Instruments Sales by Country (2017-2028)
  • 9.4.2 Latin America Non-invasive Parenteral Screening Instruments Revenue by Country (2017-2028)
  • 9.4.3 Mexico
  • 9.4.4 Brazil
  • 9.4.5 Argentina

10 Middle East and Africa

• 10.1 Middle East and Africa Non-invasive Parenteral Screening Instruments Sales Breakdown by Company
  • 10.1.1 Middle East and Africa Non-invasive Parenteral Screening Instruments Sales by Company (2017-2022)
  • 10.1.2 Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue by Company (2017-2022)
• 10.2 Middle East and Africa Non-invasive Parenteral Screening Instruments Market Size by Type
  • 10.2.1 Middle East and Africa Non-invasive Parenteral Screening Instruments Sales by Type (2017-2028)
  • 10.2.2 Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue by Type (2017-2028)
• 10.3 Middle East and Africa Non-invasive Parenteral Screening Instruments Market Size by Application
  • 10.3.1 Middle East and Africa Non-invasive Parenteral Screening Instruments Sales by Application (2017-2028)
  • 10.3.2 Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue by Application (2017-2028)
• 10.4 Middle East and Africa Non-invasive Parenteral Screening Instruments Market Size by Country
  • 10.4.1 Middle East and Africa Non-invasive Parenteral Screening Instruments Sales by Country (2017-2028)
  • 10.4.2 Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue by Country (2017-2028)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 U.A.E

11 Company Profiles

• 11.1 GE Healthcare
  • 11.1.1 GE Healthcare Corporation Information
  • 11.1.2 GE Healthcare Overview
  • 11.1.3 GE Healthcare Non-invasive Parenteral Screening Instruments Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
  • 11.1.4 GE Healthcare Non-invasive Parenteral Screening Instruments Products and Services
  • 11.1.5 GE Healthcare Non-invasive Parenteral Screening Instruments SWOT Analysis
  • 11.1.6 GE Healthcare Recent Developments
• 11.2 Philips
  • 11.2.1 Philips Corporation Information
  • 11.2.2 Philips Overview
  • 11.2.3 Philips Non-invasive Parenteral Screening Instruments Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
  • 11.2.4 Philips Non-invasive Parenteral Screening Instruments Products and Services
  • 11.2.5 Philips Non-invasive Parenteral Screening Instruments SWOT Analysis
  • 11.2.6 Philips Recent Developments
• 11.3 Illumina
  • 11.3.1 Illumina Corporation Information
  • 11.3.2 Illumina Overview
  • 11.3.3 Illumina Non-invasive Parenteral Screening Instruments Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
  • 11.3.4 Illumina Non-invasive Parenteral Screening Instruments Products and Services
  • 11.3.5 Illumina Non-invasive Parenteral Screening Instruments SWOT Analysis
  • 11.3.6 Illumina Recent Developments
• 11.4 Thermo Fisher Scientific
  • 11.4.1 Thermo Fisher Scientific Corporation Information
  • 11.4.2 Thermo Fisher Scientific Overview
  • 11.4.3 Thermo Fisher Scientific Non-invasive Parenteral Screening Instruments Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
  • 11.4.4 Thermo Fisher Scientific Non-invasive Parenteral Screening Instruments Products and Services
  • 11.4.5 Thermo Fisher Scientific Non-invasive Parenteral Screening Instruments SWOT Analysis
  • 11.4.6 Thermo Fisher Scientific Recent Developments
• 11.5 Roche
  • 11.5.1 Roche Corporation Information
  • 11.5.2 Roche Overview
  • 11.5.3 Roche Non-invasive Parenteral Screening Instruments Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
  • 11.5.4 Roche Non-invasive Parenteral Screening Instruments Products and Services
  • 11.5.5 Roche Non-invasive Parenteral Screening Instruments SWOT Analysis
  • 11.5.6 Roche Recent Developments
• 11.6 PacBio
  • 11.6.1 PacBio Corporation Information
  • 11.6.2 PacBio Overview
  • 11.6.3 PacBio Non-invasive Parenteral Screening Instruments Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
  • 11.6.4 PacBio Non-invasive Parenteral Screening Instruments Products and Services
  • 11.6.5 PacBio Non-invasive Parenteral Screening Instruments SWOT Analysis
  • 11.6.6 PacBio Recent Developments
• 11.7 Perkinelmer
  • 11.7.1 Perkinelmer Corporation Information
  • 11.7.2 Perkinelmer Overview
  • 11.7.3 Perkinelmer Non-invasive Parenteral Screening Instruments Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
  • 11.7.4 Perkinelmer Non-invasive Parenteral Screening Instruments Products and Services
  • 11.7.5 Perkinelmer Non-invasive Parenteral Screening Instruments SWOT Analysis
  • 11.7.6 Perkinelmer Recent Developments
• 11.8 Qiagen
  • 11.8.1 Qiagen Corporation Information
  • 11.8.2 Qiagen Overview
  • 11.8.3 Qiagen Non-invasive Parenteral Screening Instruments Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
  • 11.8.4 Qiagen Non-invasive Parenteral Screening Instruments Products and Services
  • 11.8.5 Qiagen Non-invasive Parenteral Screening Instruments SWOT Analysis
  • 11.8.6 Qiagen Recent Developments
• 11.9 Agilent Technologies
  • 11.9.1 Agilent Technologies Corporation Information
  • 11.9.2 Agilent Technologies Overview
  • 11.9.3 Agilent Technologies Non-invasive Parenteral Screening Instruments Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
  • 11.9.4 Agilent Technologies Non-invasive Parenteral Screening Instruments Products and Services
  • 11.9.5 Agilent Technologies Non-invasive Parenteral Screening Instruments SWOT Analysis
  • 11.9.6 Agilent Technologies Recent Developments
• 11.10 BGI Group
  • 11.10.1 BGI Group Corporation Information
  • 11.10.2 BGI Group Overview
  • 11.10.3 BGI Group Non-invasive Parenteral Screening Instruments Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
  • 11.10.4 BGI Group Non-invasive Parenteral Screening Instruments Products and Services
  • 11.10.5 BGI Group Non-invasive Parenteral Screening Instruments SWOT Analysis
  • 11.10.6 BGI Group Recent Developments

12 Value Chain and Sales Channels Analysis

• 12.1 Non-invasive Parenteral Screening Instruments Value Chain Analysis
• 12.2 Non-invasive Parenteral Screening Instruments Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Non-invasive Parenteral Screening Instruments Production Mode & Process
• 12.4 Non-invasive Parenteral Screening Instruments Sales and Marketing
  • 12.4.1 Non-invasive Parenteral Screening Instruments Sales Channels
  • 12.4.2 Non-invasive Parenteral Screening Instruments Distributors
• 12.5 Non-invasive Parenteral Screening Instruments Customers

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
  • 14.1.2 Data Source
• 14.2 Author Details
• 14.3 Disclaimer

List of Tables

• Table 1. Global Non-invasive Parenteral Screening Instruments Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
• Table 2. Major Manufacturers of Ultrasound Devices
• Table 3. Major Manufacturers of Next-Generation Sequencing Systems
• Table 4. Major Manufacturers of Polymerase Chain Reaction Instruments
• Table 5. Major Manufacturers of Microarrays
• Table 6. Major Manufacturers of Others
• Table 7. Global Non-invasive Parenteral Screening Instruments Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
• Table 8. Global Non-invasive Parenteral Screening Instruments Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
• Table 9. Global Non-invasive Parenteral Screening Instruments Sales by Region (2017-2022) & (Units)
• Table 10. Global Non-invasive Parenteral Screening Instruments Sales Market Share by Region (2017-2022)
• Table 11. Global Non-invasive Parenteral Screening Instruments Revenue by Region (2017-2022) & (US$ Million)
• Table 12. Global Non-invasive Parenteral Screening Instruments Revenue Market Share by Region (2017-2022)
• Table 13. Global Non-invasive Parenteral Screening Instruments Sales Forecast by Region (2023-2028) & (Units)
• Table 14. Global Non-invasive Parenteral Screening Instruments Sales Market Share Forecast by Region (2023-2028)
• Table 15. Global Non-invasive Parenteral Screening Instruments Revenue Forecast by Region (2023-2028) & (US$ Million)
• Table 16. Global Non-invasive Parenteral Screening Instruments Revenue Market Share Forecast by Region (2023-2028)
• Table 17. Top Non-invasive Parenteral Screening Instruments Regions (Countries) Ranking by Market Size (US$ Million) in 2021
• Table 18. Non-invasive Parenteral Screening Instruments Market Trends
• Table 19. Non-invasive Parenteral Screening Instruments Market Drivers
• Table 20. Non-invasive Parenteral Screening Instruments Market Challenges
• Table 21. Non-invasive Parenteral Screening Instruments Market Restraints
• Table 22. Global Non-invasive Parenteral Screening Instruments Sales by Manufacturers (2017-2022) & (Units)
• Table 23. Global Non-invasive Parenteral Screening Instruments Sales Share by Manufacturers (2017-2022)
• Table 24. Global Non-invasive Parenteral Screening Instruments Revenue by Manufacturers (2017-2022) & (US$ Million)
• Table 25. Ranking of Global Top Non-invasive Parenteral Screening Instruments Manufacturers by Revenue (US$ Million) in 2021
• Table 26. Non-invasive Parenteral Screening Instruments Revenue Share by Manufacturers (2017-2022)
• Table 27. Global Non-invasive Parenteral Screening Instruments Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 28. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Non-invasive Parenteral Screening Instruments as of 2021)
• Table 29. Key Manufacturers Non-invasive Parenteral Screening Instruments Average Selling Price (ASP) & (2017-2022) & (USD/Unit)
• Table 30. Key Manufacturers Non-invasive Parenteral Screening Instruments Plants/Factories Distribution
• Table 31. Key Manufacturers Non-invasive Parenteral Screening Instruments Area Served
• Table 32. Date of Key Manufacturers Enter into Non-invasive Parenteral Screening Instruments Market
• Table 33. Key Manufacturers Non-invasive Parenteral Screening Instruments Product Type
• Table 34. Mergers & Acquisitions, Expansion Plans
• Table 35. Global Non-invasive Parenteral Screening Instruments Sales (Units) by Type (2017-2022)
• Table 36. Global Non-invasive Parenteral Screening Instruments Sales Share by Type (2017-2022)
• Table 37. Global Non-invasive Parenteral Screening Instruments Revenue (US$ Million) Market Share by Type (2017-2022)
• Table 38. Global Non-invasive Parenteral Screening Instruments Price (Units) by Type (2017-2022)
• Table 39. Global Non-invasive Parenteral Screening Instruments Sales (Units) by Type (2023-2028)
• Table 40. Global Non-invasive Parenteral Screening Instruments Sales Share by Type (2023-2028)
• Table 41. Global Non-invasive Parenteral Screening Instruments Revenue (US$ Million) Market Share by Type (2023-2028)
• Table 42. Global Non-invasive Parenteral Screening Instruments Revenue Share by Type (2023-2028)
• Table 43. Global Non-invasive Parenteral Screening Instruments Price (Units) by Type (2023-2028)
• Table 44. Global Non-invasive Parenteral Screening Instruments Sales (Units) by Application (2017-2022)
• Table 45. Global Non-invasive Parenteral Screening Instruments Sales Share by Application (2017-2022)
• Table 46. Global Non-invasive Parenteral Screening Instruments Revenue (US$ Million) Market Share by Application (2017-2022)
• Table 47. Global Non-invasive Parenteral Screening Instruments Price (Units) by Application (2017-2022)
• Table 48. Global Non-invasive Parenteral Screening Instruments Sales (Units) by Application (2023-2028)
• Table 49. Global Non-invasive Parenteral Screening Instruments Sales Share by Application (2023-2028)
• Table 50. Global Non-invasive Parenteral Screening Instruments Revenue (US$ Million) Market Share by Application (2023-2028)
• Table 51. Global Non-invasive Parenteral Screening Instruments Revenue Share by Application (2023-2028)
• Table 52. Global Non-invasive Parenteral Screening Instruments Price (Units) by Application (2023-2028)
• Table 53. North America Non-invasive Parenteral Screening Instruments Sales by Company (2017-2022) & (Units)
• Table 54. North America Non-invasive Parenteral Screening Instruments Sales Market Share by Company (2017-2022)
• Table 55. North America Non-invasive Parenteral Screening Instruments Revenue by Company (2017-2022) & (US$ Million)
• Table 56. North America Non-invasive Parenteral Screening Instruments Revenue Market Share by Company (2017-2022)
• Table 57. North America Non-invasive Parenteral Screening Instruments Sales by Type (2017-2022) & (Units)
• Table 58. North America Non-invasive Parenteral Screening Instruments Sales by Type (2023-2028) & (Units)
• Table 59. North America Non-invasive Parenteral Screening Instruments Revenue by Type (2017-2022) & (US$ Million)
• Table 60. North America Non-invasive Parenteral Screening Instruments Revenue by Type (2023-2028) & (US$ Million)
• Table 61. North America Non-invasive Parenteral Screening Instruments Sales by Application (2017-2022) & (Units)
• Table 62. North America Non-invasive Parenteral Screening Instruments Sales by Application (2023-2028) & (Units)
• Table 63. North America Non-invasive Parenteral Screening Instruments Revenue by Application (2017-2022) & (US$ Million)
• Table 64. North America Non-invasive Parenteral Screening Instruments Revenue by Application (2023-2028) & (US$ Million)
• Table 65. North America Non-invasive Parenteral Screening Instruments Sales by Country (2017-2022) & (Units)
• Table 66. North America Non-invasive Parenteral Screening Instruments Sales by Country (2023-2028) & (Units)
• Table 67. North America Non-invasive Parenteral Screening Instruments Revenue by Country (2017-2022) & (US$ Million)
• Table 68. North America Non-invasive Parenteral Screening Instruments Revenue by Country (2023-2028) & (US$ Million)
• Table 69. Europe Non-invasive Parenteral Screening Instruments Sales by Company (2017-2022) & (Units)
• Table 70. Europe Non-invasive Parenteral Screening Instruments Sales Market Share by Company (2017-2022)
• Table 71. Europe Non-invasive Parenteral Screening Instruments Revenue by Company (2017-2022) & (US$ Million)
• Table 72. Europe Non-invasive Parenteral Screening Instruments Revenue Market Share by Company (2017-2022)
• Table 73. Europe Non-invasive Parenteral Screening Instruments Sales by Type (2017-2022) & (Units)
• Table 74. Europe Non-invasive Parenteral Screening Instruments Sales by Type (2023-2028) & (Units)
• Table 75. Europe Non-invasive Parenteral Screening Instruments Revenue by Type (2017-2022) & (US$ Million)
• Table 76. Europe Non-invasive Parenteral Screening Instruments Revenue by Type (2023-2028) & (US$ Million)
• Table 77. Europe Non-invasive Parenteral Screening Instruments Sales by Application (2017-2022) & (Units)
• Table 78. Europe Non-invasive Parenteral Screening Instruments Sales by Application (2023-2028) & (Units)
• Table 79. Europe Non-invasive Parenteral Screening Instruments Revenue by Application (2017-2022) & (US$ Million)
• Table 80. Europe Non-invasive Parenteral Screening Instruments Revenue by Application (2023-2028) & (US$ Million)
• Table 81. Europe Non-invasive Parenteral Screening Instruments Sales by Country (2017-2022) & (Units)
• Table 82. Europe Non-invasive Parenteral Screening Instruments Sales by Country (2023-2028) & (Units)
• Table 83. Europe Non-invasive Parenteral Screening Instruments Revenue by Country (2017-2022) & (US$ Million)
• Table 84. Europe Non-invasive Parenteral Screening Instruments Revenue by Country (2023-2028) & (US$ Million)
• Table 85. Asia Pacific Non-invasive Parenteral Screening Instruments Sales by Company (2017-2022) & (Units)
• Table 86. Asia Pacific Non-invasive Parenteral Screening Instruments Sales Market Share by Company (2017-2022)
• Table 87. Asia Pacific Non-invasive Parenteral Screening Instruments Revenue by Company (2017-2022) & (US$ Million)
• Table 88. Asia Pacific Non-invasive Parenteral Screening Instruments Revenue Market Share by Company (2017-2022)
• Table 89. Asia Pacific Non-invasive Parenteral Screening Instruments Sales by Type (2017-2022) & (Units)
• Table 90. Asia Pacific Non-invasive Parenteral Screening Instruments Sales by Type (2023-2028) & (Units)
• Table 91. Asia Pacific Non-invasive Parenteral Screening Instruments Revenue by Type (2017-2022) & (US$ Million)
• Table 92. Asia Pacific Non-invasive Parenteral Screening Instruments Revenue by Type (2023-2028) & (US$ Million)
• Table 93. Asia Pacific Non-invasive Parenteral Screening Instruments Sales by Application (2017-2022) & (Units)
• Table 94. Asia Pacific Non-invasive Parenteral Screening Instruments Sales by Application (2023-2028) & (Units)
• Table 95. Asia Pacific Non-invasive Parenteral Screening Instruments Revenue by Application (2017-2022) & (US$ Million)
• Table 96. Asia Pacific Non-invasive Parenteral Screening Instruments Revenue by Application (2023-2028) & (US$ Million)
• Table 97. Asia Pacific Non-invasive Parenteral Screening Instruments Sales by Region (2017-2022) & (Units)
• Table 98. Asia Pacific Non-invasive Parenteral Screening Instruments Sales by Region (2023-2028) & (Units)
• Table 99. Asia Pacific Non-invasive Parenteral Screening Instruments Revenue by Region (2017-2022) & (US$ Million)
• Table 100. Asia Pacific Non-invasive Parenteral Screening Instruments Revenue by Region (2023-2028) & (US$ Million)
• Table 101. Latin America Non-invasive Parenteral Screening Instruments Sales by Company (2017-2022) & (Units)
• Table 102. Latin America Non-invasive Parenteral Screening Instruments Sales Market Share by Company (2017-2022)
• Table 103. Latin America Non-invasive Parenteral Screening Instruments Revenue by Company (2017-2022) & (US$ Million)
• Table 104. Latin America Non-invasive Parenteral Screening Instruments Revenue Market Share by Company (2017-2022)
• Table 105. Latin America Non-invasive Parenteral Screening Instruments Sales by Type (2017-2022) & (Units)
• Table 106. Latin America Non-invasive Parenteral Screening Instruments Sales by Type (2023-2028) & (Units)
• Table 107. Latin America Non-invasive Parenteral Screening Instruments Revenue by Type (2017-2022) & (US$ Million)
• Table 108. Latin America Non-invasive Parenteral Screening Instruments Revenue by Type (2023-2028) & (US$ Million)
• Table 109. Latin America Non-invasive Parenteral Screening Instruments Sales by Application (2017-2022) & (Units)
• Table 110. Latin America Non-invasive Parenteral Screening Instruments Sales by Application (2023-2028) & (Units)
• Table 111. Latin America Non-invasive Parenteral Screening Instruments Revenue by Application (2017-2022) & (US$ Million)
• Table 112. Latin America Non-invasive Parenteral Screening Instruments Revenue by Application (2023-2028) & (US$ Million)
• Table 113. Latin America Non-invasive Parenteral Screening Instruments Sales by Country (2017-2022) & (Units)
• Table 114. Latin America Non-invasive Parenteral Screening Instruments Sales by Country (2023-2028) & (Units)
• Table 115. Latin America Non-invasive Parenteral Screening Instruments Revenue by Country (2017-2022) & (US$ Million)
• Table 116. Latin America Non-invasive Parenteral Screening Instruments Revenue by Country (2023-2028) & (US$ Million)
• Table 117. Middle East and Africa Non-invasive Parenteral Screening Instruments Sales by Company (2017-2022) & (Units)
• Table 118. Middle East and Africa Non-invasive Parenteral Screening Instruments Sales Market Share by Company (2017-2022)
• Table 119. Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue by Company (2017-2022) & (US$ Million)
• Table 120. Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue Market Share by Company (2017-2022)
• Table 121. Middle East and Africa Non-invasive Parenteral Screening Instruments Sales by Type (2017-2022) & (Units)
• Table 122. Middle East and Africa Non-invasive Parenteral Screening Instruments Sales by Type (2023-2028) & (Units)
• Table 123. Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue by Type (2017-2022) & (US$ Million)
• Table 124. Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue by Type (2023-2028) & (US$ Million)
• Table 125. Middle East and Africa Non-invasive Parenteral Screening Instruments Sales by Application (2017-2022) & (Units)
• Table 126. Middle East and Africa Non-invasive Parenteral Screening Instruments Sales by Application (2023-2028) & (Units)
• Table 127. Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue by Application (2017-2022) & (US$ Million)
• Table 128. Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue by Application (2023-2028) & (US$ Million)
• Table 129. Middle East and Africa Non-invasive Parenteral Screening Instruments Sales by Country (2017-2022) & (Units)
• Table 130. Middle East and Africa Non-invasive Parenteral Screening Instruments Sales by Country (2023-2028) & (Units)
• Table 131. Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue by Country (2017-2022) & (US$ Million)
• Table 132. Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue by Country (2023-2028) & (US$ Million)
• Table 133. GE Healthcare Corporation Information
• Table 134. GE Healthcare Description and Overview
• Table 135. GE Healthcare Non-invasive Parenteral Screening Instruments Sales (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
• Table 136. GE Healthcare Non-invasive Parenteral Screening Instruments Product and Services
• Table 137. GE Healthcare Non-invasive Parenteral Screening Instruments SWOT Analysis
• Table 138. GE Healthcare Recent Developments
• Table 139. Philips Corporation Information
• Table 140. Philips Description and Overview
• Table 141. Philips Non-invasive Parenteral Screening Instruments Sales (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
• Table 142. Philips Non-invasive Parenteral Screening Instruments Product and Services
• Table 143. Philips Non-invasive Parenteral Screening Instruments SWOT Analysis
• Table 144. Philips Recent Developments
• Table 145. Illumina Corporation Information
• Table 146. Illumina Description and Overview
• Table 147. Illumina Non-invasive Parenteral Screening Instruments Sales (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
• Table 148. Illumina Non-invasive Parenteral Screening Instruments Product and Services
• Table 149. Illumina Non-invasive Parenteral Screening Instruments SWOT Analysis
• Table 150. Illumina Recent Developments
• Table 151. Thermo Fisher Scientific Corporation Information
• Table 152. Thermo Fisher Scientific Description and Overview
• Table 153. Thermo Fisher Scientific Non-invasive Parenteral Screening Instruments Sales (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
• Table 154. Thermo Fisher Scientific Non-invasive Parenteral Screening Instruments Product and Services
• Table 155. Thermo Fisher Scientific Non-invasive Parenteral Screening Instruments SWOT Analysis
• Table 156. Thermo Fisher Scientific Recent Developments
• Table 157. Roche Corporation Information
• Table 158. Roche Description and Overview
• Table 159. Roche Non-invasive Parenteral Screening Instruments Sales (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
• Table 160. Roche Non-invasive Parenteral Screening Instruments Product and Services
• Table 161. Roche Non-invasive Parenteral Screening Instruments SWOT Analysis
• Table 162. Roche Recent Developments
• Table 163. PacBio Corporation Information
• Table 164. PacBio Description and Overview
• Table 165. PacBio Non-invasive Parenteral Screening Instruments Sales (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
• Table 166. PacBio Non-invasive Parenteral Screening Instruments Product and Services
• Table 167. PacBio Non-invasive Parenteral Screening Instruments SWOT Analysis
• Table 168. PacBio Recent Developments
• Table 169. Perkinelmer Corporation Information
• Table 170. Perkinelmer Description and Overview
• Table 171. Perkinelmer Non-invasive Parenteral Screening Instruments Sales (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
• Table 172. Perkinelmer Non-invasive Parenteral Screening Instruments Product and Services
• Table 173. Perkinelmer Non-invasive Parenteral Screening Instruments SWOT Analysis
• Table 174. Perkinelmer Recent Developments
• Table 175. Qiagen Corporation Information
• Table 176. Qiagen Description and Overview
• Table 177. Qiagen Non-invasive Parenteral Screening Instruments Sales (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
• Table 178. Qiagen Non-invasive Parenteral Screening Instruments Product and Services
• Table 179. Qiagen Non-invasive Parenteral Screening Instruments SWOT Analysis
• Table 180. Qiagen Recent Developments
• Table 181. Agilent Technologies Corporation Information
• Table 182. Agilent Technologies Description and Overview
• Table 183. Agilent Technologies Non-invasive Parenteral Screening Instruments Sales (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
• Table 184. Agilent Technologies Non-invasive Parenteral Screening Instruments Product and Services
• Table 185. Agilent Technologies Non-invasive Parenteral Screening Instruments SWOT Analysis
• Table 186. Agilent Technologies Recent Developments
• Table 187. BGI Group Corporation Information
• Table 188. BGI Group Description and Overview
• Table 189. BGI Group Non-invasive Parenteral Screening Instruments Sales (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
• Table 190. BGI Group Non-invasive Parenteral Screening Instruments Product and Services
• Table 191. BGI Group Non-invasive Parenteral Screening Instruments SWOT Analysis
• Table 192. BGI Group Recent Developments
• Table 193. Key Raw Materials Lists
• Table 194. Raw Materials Key Suppliers Lists
• Table 195. Non-invasive Parenteral Screening Instruments Distributors List
• Table 196. Non-invasive Parenteral Screening Instruments Customers List
• Table 197. Research Programs/Design for This Report
• Table 198. Key Data Information from Secondary Sources
• Table 199. Key Data Information from Primary Sources

List of Figures

• Figure 1. Non-invasive Parenteral Screening Instruments Product Picture
• Figure 2. Global Non-invasive Parenteral Screening Instruments Sales Market Share by Type in 2021 & 2028
• Figure 3. Ultrasound Devices Product Picture
• Figure 4. Next-Generation Sequencing Systems Product Picture
• Figure 5. Polymerase Chain Reaction Instruments Product Picture
• Figure 6. Microarrays Product Picture
• Figure 7. Others Product Picture
• Figure 8. Global Non-invasive Parenteral Screening Instruments Sales Market Share by Application in 2021 & 2028
• Figure 9. Diagnostic Laboratories Use Case
• Figure 10. Hospitals Use Case
• Figure 11. Non-invasive Parenteral Screening Instruments Report Years Considered
• Figure 12. Global Non-invasive Parenteral Screening Instruments Revenue, (US$ Million), 2017 VS 2021 VS 2028
• Figure 13. Global Non-invasive Parenteral Screening Instruments Market Size 2017-2028 (US$ Million)
• Figure 14. Global Non-invasive Parenteral Screening Instruments Sales (2017-2022) & (Units)
• Figure 15. Global Non-invasive Parenteral Screening Instruments Market Size Market Share by Region: 2021 VS 2028
• Figure 16. Global Non-invasive Parenteral Screening Instruments Sales Market Share by Region (2017-2022)
• Figure 17. Global Non-invasive Parenteral Screening Instruments Sales Market Share by Region in 2021
• Figure 18. Global Non-invasive Parenteral Screening Instruments Revenue Market Share by Region in 2017 VS 2021
• Figure 19. Global Non-invasive Parenteral Screening Instruments Sales Share by Manufacturers in 2021
• Figure 20. The 5 and 10 Largest Manufacturers in the World: Market Share by Non-invasive Parenteral Screening Instruments Sales in 2021
• Figure 21. Non-invasive Parenteral Screening Instruments Revenue Share by Manufacturers in 2021
• Figure 22. Non-invasive Parenteral Screening Instruments Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
• Figure 23. Global Non-invasive Parenteral Screening Instruments Revenue Share by Type (2017-2022)
• Figure 24. Global Non-invasive Parenteral Screening Instruments Revenue Growth Rate by Type in 2017 & 2021
• Figure 25. Global Non-invasive Parenteral Screening Instruments Revenue Share by Application (2017-2022)
• Figure 26. Global Non-invasive Parenteral Screening Instruments Revenue Growth Rate by Application in 2017 & 2021
• Figure 27. North America Non-invasive Parenteral Screening Instruments Sales Market Share by Type (2017-2028)
• Figure 28. North America Non-invasive Parenteral Screening Instruments Revenue Market Share by Type (2017-2028)
• Figure 29. North America Non-invasive Parenteral Screening Instruments Sales Market Share by Application (2017-2028)
• Figure 30. North America Non-invasive Parenteral Screening Instruments Revenue Market Share by Application (2017-2028)
• Figure 31. North America Non-invasive Parenteral Screening Instruments Sales Share by Country (2017-2028)
• Figure 32. North America Non-invasive Parenteral Screening Instruments Revenue Share by Country (2017-2028)
• Figure 33. U.S. Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
• Figure 34. Canada Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
• Figure 35. Europe Non-invasive Parenteral Screening Instruments Sales Market Share by Type (2017-2028)
• Figure 36. Europe Non-invasive Parenteral Screening Instruments Revenue Market Share by Type (2017-2028)
• Figure 37. Europe Non-invasive Parenteral Screening Instruments Sales Market Share by Application (2017-2028)
• Figure 38. Europe Non-invasive Parenteral Screening Instruments Revenue Market Share by Application (2017-2028)
• Figure 39. Europe Non-invasive Parenteral Screening Instruments Sales Share by Country (2017-2028)
• Figure 40. Europe Non-invasive Parenteral Screening Instruments Revenue Share by Country (2017-2028)
• Figure 41. Germany Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
• Figure 42. France Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
• Figure 43. U.K. Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
• Figure 44. Italy Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
• Figure 45. Russia Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
• Figure 46. Asia Pacific Non-invasive Parenteral Screening Instruments Sales Market Share by Type (2017-2028)
• Figure 47. Asia Pacific Non-invasive Parenteral Screening Instruments Revenue Market Share by Type (2017-2028)
• Figure 48. Asia Pacific Non-invasive Parenteral Screening Instruments Sales Market Share by Application (2017-2028)
• Figure 49. Asia Pacific Non-invasive Parenteral Screening Instruments Revenue Market Share by Application (2017-2028)
• Figure 50. Asia Pacific Non-invasive Parenteral Screening Instruments Sales Share by Region (2017-2028)
• Figure 51. Asia Pacific Non-invasive Parenteral Screening Instruments Revenue Share by Region (2017-2028)
• Figure 52. China Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
• Figure 53. Japan Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
• Figure 54. South Korea Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
• Figure 55. India Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
• Figure 56. Australia Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
• Figure 57. Taiwan Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
• Figure 58. Indonesia Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
• Figure 59. Thailand Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
• Figure 60. Malaysia Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
• Figure 61. Philippines Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
• Figure 62. Vietnam Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
• Figure 63. Latin America Non-invasive Parenteral Screening Instruments Sales Market Share by Type (2017-2028)
• Figure 64. Latin America Non-invasive Parenteral Screening Instruments Revenue Market Share by Type (2017-2028)
• Figure 65. Latin America Non-invasive Parenteral Screening Instruments Sales Market Share by Application (2017-2028)
• Figure 66. Latin America Non-invasive Parenteral Screening Instruments Revenue Market Share by Application (2017-2028)
• Figure 67. Latin America Non-invasive Parenteral Screening Instruments Sales Share by Country (2017-2028)
• Figure 68. Latin America Non-invasive Parenteral Screening Instruments Revenue Share by Country (2017-2028)
• Figure 69. Mexico Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
• Figure 70. Brazil Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
• Figure 71. Argentina Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
• Figure 72. Middle East and Africa Non-invasive Parenteral Screening Instruments Sales Market Share by Type (2017-2028)
• Figure 73. Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue Market Share by Type (2017-2028)
• Figure 74. Middle East and Africa Non-invasive Parenteral Screening Instruments Sales Market Share by Application (2017-2028)
• Figure 75. Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue Market Share by Application (2017-2028)
• Figure 76. Middle East and Africa Non-invasive Parenteral Screening Instruments Sales Share by Country (2017-2028)
• Figure 77. Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue Share by Country (2017-2028)
• Figure 78. Turkey Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
• Figure 79. Saudi Arabia Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
• Figure 80. U.A.E Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
• Figure 81. Non-invasive Parenteral Screening Instruments Value Chain
• Figure 82. Non-invasive Parenteral Screening Instruments Production Process
• Figure 83. Channels of Distribution
• Figure 84. Distributors Profiles
• Figure 85. Bottom-up and Top-down Approaches for This Report
• Figure 86. Data Triangulation
• Figure 87. Key Executives Interviewed